Zongfang Li

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway

Kunlun Chen, Shu Zhang, Yuanyuan Ji et al. · PLoS ONE · 2013 · 138 citations · Full text

Metastatic Capabilities, Chemoprevention Strategy, Hepatocellular Carcinoma Cells +17

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Baiyan Wang, Wanhong Zhao, Jie Liu et al. · Blood · 2019 · 91 citations

Randomized Controlled Trial of Early Rehabilitation After Intracerebral Hemorrhage Stroke

Ning Liu, Dominique A. Cadilhac, Nadine E. Andrew et al. · Stroke · 2014 · 85 citations · Full text

Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study

Jian Zu, Miaolei Li, Zongfang Li et al. · Infectious Diseases of Poverty · 2020 · 71 citations · Full text